Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy

被引:298
|
作者
Rubinshtein, Ronen [1 ]
Glockner, James F. [2 ]
Ommen, Steve R. [1 ]
Araoz, Philip A. [2 ]
Ackerman, Michael J. [1 ,3 ,4 ,5 ]
Sorajja, Paul [1 ]
Bos, J. Martijn [5 ]
Tajik, A. Jamil [6 ]
Valeti, Uma S. [1 ]
Nishimura, Rick A. [1 ]
Gersh, Bernard J. [1 ]
机构
[1] Mayo Clin, Div Cardiovasc Dis, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Pediat, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA
[5] Mayo Clin, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN 55905 USA
[6] Mayo Clin, Div Cardiovasc Dis, Scottsdale, AZ USA
关键词
hypertrophic cardiomyopathy; magnetic resonance imaging; late gadolinium enhancement; sudden death and risk assessment; SURGICAL SEPTAL MYECTOMY; SUDDEN CARDIAC DEATH; DELAYED ENHANCEMENT; RISK; YOUNG; DEFIBRILLATORS; SYMPTOMS; FIBROSIS; ABLATION;
D O I
10.1161/CIRCHEARTFAILURE.109.854026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Myocardial late gadolinium enhancement (LGE) on contrast-enhanced magnetic resonance imaging (CE-MRI) of patients with hypertrophic cardiomyopathy (HCM) has been suggested to represent intramyocardial fibrosis and, as such, an adverse prognostic risk factor. We evaluated the characteristics of LGE on CE-MRI and explored whether LGE among patients with HCM was associated with genetic testing, severe symptoms, ventricular arrhythmias, or sudden cardiac death (SCD). Methods and Results-Four hundred twenty-four patients with HCM (age=55+/-16 years [range 2 to 90], 41% females), without a history of septal ablation/myectomy, underwent CE-MRI (GE 1.5 Tesla). We evaluated the relation between LGE and HCM genes status, severity of symptoms, and the degree of ventricular ectopy on Holter ECG. Subsequent SCD and appropriate implanted cardioverter defibrillator (ICD) therapies were recorded during a mean follow-up of 43+/-14 months (range 16 to 94). Two hundred thirty-nine patients (56%) had LGE on CE-MRI, ranging from 0.4% to 65% of the left ventricle. Gene-positive patients were more likely to have LGE (P<0.001). The frequencies of New York Heart Association class >= 3 dyspnea and angina class >= 3 were similar in patients with and without LGE (125 of 239 [52%] versus 94 of 185 [51%] and 24 of 239 [10%] versus 18 of 185 [10%], respectively, P=NS). LGE-positive patients were more likely to have episodes of nonsustained ventricular tachycardia (34 of 126 [27%] versus 8 of 94 [8.5%], P<0.001), had more episodes of nonsustained ventricular tachycardia per patient (4.5+/-12 versus 1.1+/-0.3, P=0.04), and had higher frequency of ventricular extrasystoles/24 hours (700+/-2080 versus 103+/-460, P=0.003). During follow-up, SCD occurred in 4 patients, and additional 4 patients received appropriate ICD discharges. All 8 patients were LGE positive (event rate of 0.94%/y, P=0.01 versus LGE negative). Two additional heart failure-related deaths were recorded among LGE-positive patients. Univariate associates of SCD or appropriate ICD discharge were positive LGE (P=0.002) and presence of nonsustained ventricular tachycardia (P=0.04). The association of LGE with events remained significant after controlling for other risk factors. Conclusions-In patients with HCM, presence of LGE on CE-MRI was common and more prevalent among gene-positive patients. LGE was not associated with severe symptoms. However, LGE was strongly associated with surrogates of arrhythmia and remained a significant associate of subsequent SCD and/or ICD discharge after controlling for other variables. If replicated, LGE may be considered an important risk factor for sudden death in patients with HCM. (Circ Heart Fail. 2010; 3: 51-58.)
引用
收藏
页码:51 / 58
页数:8
相关论文
共 50 条
  • [1] Prevalence and Signal Characteristics of Late Gadolinium Enhancement on Contrast-Enhanced Magnetic Resonance Imaging in Patients With Takotsubo Cardiomyopathy
    Nakamori, Shiro
    Matsuoka, Koji
    Onishi, Katsuya
    Kurita, Tairo
    Ichikawa, Yasutaka
    Nakajima, Hiroshi
    Ishida, Masaki
    Kitagawa, Kakuya
    Tanigawa, Takashi
    Nakamura, Tomoaki
    Ito, Masaaki
    Sakuma, Hajime
    CIRCULATION JOURNAL, 2012, 76 (04) : 914 - 921
  • [2] Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
    Dumont, Carlos A.
    Monserrat, Lorenzo
    Soler, Rafaela
    Rodriguez, Esther
    Fernandez, Xusto
    Peteiro, Jess
    Bouzas, Beatriz
    Pinon, Pablo
    Castro-Beiras, Alfonso
    REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (01): : 15 - 23
  • [3] Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy
    He, Dongmei
    Ye, Min
    Zhang, Liwen
    Jiang, Binghu
    HEART & LUNG, 2018, 47 (02): : 122 - 126
  • [4] Hypertrophic Cardiomyopathy: Quantification of Late Gadolinium Enhancement with Contrast-enhanced Cardiovascular MR Imaging
    Harrigan, Caitlin J.
    Peters, Dana C.
    Gibson, C. Michael
    Maron, Barry J.
    Manning, Warren J.
    Maron, Martin S.
    Appelbaum, Evan
    RADIOLOGY, 2011, 258 (01) : 128 - 133
  • [5] Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance
    Caetano, Francisca
    Botelho, Ana
    Trigo, Joana
    Silva, Joana
    Almeida, Ines
    Venancio, Margarida
    Pais, Joao
    Sanches, Conceicao
    Marques, Antonio Leitao
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2014, 33 (05) : 261 - 267
  • [6] Utility of late gadolinium enhancement on magnetic resonance imaging in hypertrophic cardiomyopathy patients in an Indian cohort
    Gangadharakaimal, Harikrishnan
    Parashar, Nitin Kumar
    Prabhu, Mukund A.
    Anoop, Ayyappan
    Namboodiri, Narayanan
    INDIAN HEART JOURNAL, 2023, 75 (05) : 383 - 385
  • [7] Extent of Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in Japanese Hypertrophic Cardiomyopathy Patients
    Hen, Yasuki
    Iguchi, Nobuo
    Utanohara, Yuko
    Takada, Kaori
    Machida, Haruhiko
    Takara, Ayako
    Teraoka, Kunihiko
    Sumiyoshi, Tetsuya
    Takamisawa, Itaru
    Takayama, Morimasa
    Yoshikawa, Tsutomu
    CIRCULATION JOURNAL, 2016, 80 (04) : 950 - 957
  • [8] Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction
    Funada, Akira
    Kanzaki, Hideaki
    Noguchi, Teruo
    Morita, Yoshiaki
    Sugano, Yasuo
    Ohara, Takahiro
    Hasegawa, Takuya
    Hashimura, Hiromi
    Ishibashi-Ueda, Hatsue
    Kitakaze, Masafumi
    Yasuda, Satoshi
    Ogawa, Hisao
    Anzai, Toshihisa
    HEART AND VESSELS, 2016, 31 (05) : 758 - 770
  • [9] Prognostic Value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic Cardiomyopathy
    Green, John J.
    Berger, Jeffery S.
    Kramer, Christopher M.
    Salerno, Michael
    JACC-CARDIOVASCULAR IMAGING, 2012, 5 (04) : 370 - 377
  • [10] Prognostic Value of Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in Japanese Hypertrophic Cardiomyopathy Patients
    Hen, Yasuki
    Iguchi, Nobuo
    Utanohara, Yuko
    Takada, Kaori
    Machida, Haruhiko
    Takayama, Morimasa
    Sumiyoshi, Tetsuya
    CIRCULATION JOURNAL, 2014, 78 (04) : 929 - 937